Extracellular vesicle-mediated cell-cell communication in keloids and hypertrophic scars: mechanisms, methodological caveats, and therapeutic perspectives
Lu B., Jin J., Jin W., Yuan X., Jin Z.
Narrative Review on Scar, Chronic Inflammation, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Cell Dev Biol (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42306298
- PMCID
- PMC13265475
- DOI
- 10.3389/fcell.2026.1818463
Abstract (original English)
Pathological scarring, including keloids and hypertrophic scars, remains a major clinical challenge characterized by persistent fibroblast activation, excessive extracellular matrix deposition, chronic inflammation, and aberrant tissue remodeling. Although current treatments have improved management, high recurrence rates and variable outcomes indicate that the underlying mechanisms remain incompletely understood. Extracellular vesicles (EVs), especially small extracellular vesicles (sEVs), are increasingly recognized as mediators of intercellular communication in fibrotic skin disorders. However, according to MISEV recommendations, the term "exosome" should be used cautiously unless endosomal origin is specifically demonstrated. In pathological scars, EV-/sEV-mediated signaling has been implicated in fibroblast activation, immune dysregulation, angiogenic imbalance, and extracellular matrix remodeling through cargo transfer among fibroblasts, keratinocytes, endothelial cells, immune cells, and mesenchymal stromal/stem cells. Reported downstream pathways include TGF-β/Smad, Wnt/β-catenin, PI3K/Akt, and NF-κB. However, the strength of evidence varies substantially, as many conclusions are based on in vitro studies or correlative omics analyses rather than direct causal experiments. In addition, differences in EV isolation and characterization methods may significantly affect rep
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level AMeta-analysisPubMed
Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 323 on Scar, published in Eur J Obstet Gynecol Reprod Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 323
Eur J Obstet Gynecol Reprod Biol - Level AMeta-analysisEurope PMC
Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis
Meta-analysis on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewEurope PMC
Comparative Efficacy and Safety of Fractional CO<sub>2</sub> Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review
Systematic Review on Chronic Wound, Scar, published in Skin Res Technol (2026) — summary generated from the PubMed abstract.
- 2026
Skin Res Technol - Level AMeta-analysisPubMed
Role of exosome therapy in reconstructive surgery: a review.
Meta-analysis on Chronic Wound, Scar, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne)1 citations